Atrial fibrillation: antiarrhythmic therapy

Area of Science:

• Cardiology
• Pharmacology
• Internal Medicine

Background:

• Atrial fibrillation (AF) is a prevalent cardiac arrhythmia with substantial morbidity, mortality, and economic burden.
• Anticoagulation is crucial in AF management, but rhythm control strategies also play a significant role.
• Current therapeutic options for AF are diverse, with ongoing development, yet no single best strategy is universally established.

Purpose of the Study:

• To review the evidence supporting various pharmacological agents used in atrial fibrillation treatment.
• To provide a clinical decision-making framework for initiating and managing AF therapy.
• To discuss the balance between rate and rhythm control strategies in AF management.

Main Methods:

• Systematic review of existing literature on atrial fibrillation pharmacotherapy.
• Analysis of clinical trial data and guidelines for AF management.
• Evaluation of efficacy and side effect profiles of different antiarrhythmic and anticoagulant agents.

Main Results:

• Multiple therapeutic strategies exist for AF, including rate and rhythm control.
• Agent selection depends on patient-specific factors like preference, comorbidities, and drug profiles.
• Evidence supports various agents, but optimal strategy choice remains individualized.

Conclusions:

• Effective management of atrial fibrillation requires careful consideration of anticoagulation and rhythm control.
• Individualized treatment plans, balancing efficacy, safety, and patient factors, are essential for optimal AF care.
• This review offers a framework to guide clinicians in selecting and managing AF therapies.